A little over half of the 37 large-cap schemes have underperformed the Nifty100 index year-to-date.
Seventeen schemes beat the benchmark’s returns of -6.4 per cent given this year, of which only three schemes have provided positive returns, data from Value Research shows. JM Core 11 Fund has been the worst performer, with returns of -17.6 per cent. Only regular plans were considered.
The Nifty50 has rallied thanks to the outperformance of a select few names such as Dr Reddy’s Laboratories, Divi’s Laboratories, Cipla, Infosys, Reliance Industries, and Wipro. In the Nifty100 universe, only 29 per cent of stocks have provided double-digit returns,